Skip to main content
. Author manuscript; available in PMC: 2023 May 23.
Published in final edited form as: Lancet Infect Dis. 2021 Apr 14;21(8):1120–1128. doi: 10.1016/S1473-3099(21)00142-0

Table 3:

Prevalence of day 3 parasitaemia and Pfkelch13 R561H mutation in pre-treatment isolates in the three study sites

Day 3 parasitaemia positive
Day 3 parasitaemia negative
561H mutation R561 wildtype 561H mutation R561 wildtype

Rukara (n=82) 5 (6·1%) 7 (8·5%) 13 (15·9%) 57 (69·5%)
Masaka (n=51) 6 (11·8%) 2 (3·9%) 4 (7·8%) 39 (76·5%)
Bugarama (n=85) 0 (0·0%) 0 (0·0%) 0 (0·0%) 85 (100%)

Data are n (%). Pfkelch13=Plasmodium falciparum kelch 13.